NEW YORK, Jan 29 - Incyte and UK-based Oxagen have announced a collaboration, in which the two companies will jointly investigate genes related to osteoporosis for drug target validation and discovery, and Oxagen will receive access to Incyte’s LifeSeq gold database for use in its disease areas, the companies announced Monday.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.